Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Camboni

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The American Journal of Gastroenterology|July 1, 1985
Gastrointestinal transit in hyperthyroid patients before and after propranolol treatmentA Bozzani, M G Camboni, L Tidone, et al.
Anti-Cancer Drugs|April 20, 2004
Phase I clinical and pharmacokinetic study of BBR 3576, a novel aza-anthrapyrazole, administered i.v. every 4 weeks in patients with advanced solid tumors: a phase I study group trial of the Central European Society of Anticancer-Drug Research (CESAR)Klaus Mross, Max E Scheulen, Thomas Licht, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2004
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinomaD I Jodrell, T R J Evans, W Steward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complexC Sessa, G Capri, L Gianni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumorsJ-C Soria, F DeBraud, R Bahleda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2020
Corrections to "Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors"J-C Soria, F DeBraud, R Bahleda, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The American Journal of Gastroenterology|July 1, 1985
Gastrointestinal transit in hyperthyroid patients before and after propranolol treatmentA Bozzani, M G Camboni, L Tidone, et al.
Anti-Cancer Drugs|April 20, 2004
Phase I clinical and pharmacokinetic study of BBR 3576, a novel aza-anthrapyrazole, administered i.v. every 4 weeks in patients with advanced solid tumors: a phase I study group trial of the Central European Society of Anticancer-Drug Research (CESAR)Klaus Mross, Max E Scheulen, Thomas Licht, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2004
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinomaD I Jodrell, T R J Evans, W Steward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complexC Sessa, G Capri, L Gianni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumorsJ-C Soria, F DeBraud, R Bahleda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2020
Corrections to "Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors"J-C Soria, F DeBraud, R Bahleda, et al.
Pageof 3